Cargando…

Immunoliposomes-mediated small interfering RNA therapy: A novel approach for the treatment of cancer

Detalles Bibliográficos
Autor principal:	Khan, Arif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Qassim Uninversity 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436446/ https://www.ncbi.nlm.nih.gov/pubmed/30983938

Ejemplares similares

Small interfering RNA: a tailored approach to explore the therapeutic potential in COVID-19
por: Gatta, Aditya Kiran, et al.
Publicado: (2021)

Small interfering RNA-based molecular therapy of cancers
por: Guo, Wei, et al.
Publicado: (2013)

Small interfering RNA (siRNA): a hope for the loss-of-function studies in anesthesiology?
por: Kim, Yun Hong
Publicado: (2010)

Delivering Small Interfering RNA for Novel Therapeutics
por: Lu, Patrick Y., et al.
Publicado: (2008)

Fatty Acid Synthase (FASN) siRNA-Encapsulated-Her-2 Targeted Fab’-Immunoliposomes for Gene Silencing in Breast Cancer Cells
por: Khan, Arif, et al.
Publicado: (2020)

Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy
por: Xie, Junlin, et al.
Publicado: (2022)

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
por: Carugo, S., et al.
Publicado: (2023)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
por: Miele, Evelina, et al.
Publicado: (2012)

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
por: Vingerhoeds, M. H., et al.
Publicado: (1996)

Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma
por: Song, Liu, et al.
Publicado: (2016)

Novel method for screening functional antibody with comprehensive analysis of its immunoliposome
por: Hamamichi, Shusei, et al.
Publicado: (2021)

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022)

Immunoliposomes for detection of rupture-prone intracranial aneurysms
por: Jahromi, Behnam Rezai, et al.
Publicado: (2023)

Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation
por: Lin, Jiatian, et al.
Publicado: (2020)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2019)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Colored petri net modeling of small interfering RNA-mediated messenger RNA degradation
por: Nickaeen, Niloofar, et al.
Publicado: (2016)

Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2020)

Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment
por: Wang, Zhiliang, et al.
Publicado: (2013)

INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapy
por: Herranz, Daniel
Publicado: (2022)

Liposomal thymoquinone, a novel drug formulation: Hope for lung cancer treatment
por: Khan, Arif
Publicado: (2021)

Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells
por: Koning, G A, et al.
Publicado: (1999)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2021)

AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma
por: Wang, Xiaoyong, et al.
Publicado: (2017)

Small Interfering RNA Inhibition of Andes Virus Replication
por: Chiang, Cheng-Feng, et al.
Publicado: (2014)

Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
por: Hosokawa, S, et al.
Publicado: (2003)

Interfering with type I Interferon: A novel approach to purge persistent viral infection
por: Wilson, Elizabeth B, et al.
Publicado: (2013)

Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
por: Mirzaei, Sepideh, et al.
Publicado: (2021)

Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system
por: He, Junkun, et al.
Publicado: (2012)

Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes
por: Liu, Jianye, et al.
Publicado: (2019)

Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study
por: Matusewicz, Lucyna, et al.
Publicado: (2018)

Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel
por: Khayrani, Apriliana Cahya, et al.
Publicado: (2019)

Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018)

Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation
por: Wang, Ping, et al.
Publicado: (2011)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
por: Zheng, Zhong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9iogn7bc37abuebiur5m15oqgh